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A Review
Daniel C. Hatton, David A. McCarron R estricted dietary calcium intake has been linked to elevated blood pressure in a number of epidemiologic studies. These findings, in conjunction with indications of calcium deficiency in clinical hypertension, suggest that repletion of dietary calcium may have a beneficial effect on blood pressure. This possibility has been explored extensively in both humans and animal models of hypertension. In this article, we review the animal work relating dietary calcium to blood pressure and examine some of the mechanisms that may be responsible. Much of the content is based on published experiments and earlier reviews by our laboratory on this subject. '-3 
Background Calcium Metabolism in Experimental and Essential Hypertension
More than 20 epidemiologic investigations have reported an inverse relation between dietary calcium intake and blood pressure status/- 28 The increased risk of elevated blood pressure with lower calcium intake appears to be related to an apparent deficit in calcium metabolism that occurs in a subset of hypertensive individuals. That deficit appears systemically as a small increase in circulating parathyroid hormone (PTH) 29 -30 levels, reduced serum phosphorus, 31 and increased urinary calcium excretion. 3238 At the cellular level, the deficit in calcium metabolism is reflected in elevated intracellular free calcium levels, as indicated by studies examining platelets isolated from individuals with essential hypertension. 39 -47 The alterations in calcium metabolism observed in hypertensive humans are mirrored in experimental models of hypertension. Plasma ionized calcium has been reported to be decreased in the spontaneously hypertensive rat (SHR) relative to the normotensive Wistar-Kyoto (WKY) rat, 48 - 51 whereas PTH has been observed to be either elevated or unchanged. 49 - 51 End-organ responsiveness to PTH appears to be abnormal based on findings of hypercalciuria, 51 
"
54 decreased basal and stimulated 1,25-dihydroxyvitamin D 3 [1, 25 (OH)2 vitamin D 3 ] production, 55 
58 and low to normal urinary nephrogenous cyclic
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AMP in the presence of elevated PTH. 52 -59 ' 60 At the cellular level, SHR exhibit depressed ATP-dependent calcium uptake capacity in crude microsomal fractions of aorta as well as in more purified sarcolemmal fractions of the mesenteric artery. 61 " 66 Therefore, it has been suggested that the vascular myocyte may not be able to maintain normal levels of intracellular calcium or properly remove calcium after activation. 67 It appears that the cell membrane of the SHR as exemplified by platelets and lymphocytes may be hyperpermeable to calcium because both basal and agonist-stimulated calcium uptake have been found to be elevated in the SHR. 68 " 71 Consequently, the SHR has abnormally high intracellular free calcium levels, as has been observed in essential hypertensive patients.
The inverse relation between dietary calcium and blood pressure identified through epidemiologic investigations suggests that supplemental dietary calcium may lower blood pressure. Numerous studies have tested this possibility. Of the published studies of calcium supplementation in humans, 24 reported a significant reduction in blood pressure 7295 in at least a segment of the study population, and 13 reported no difference in blood pressure. 96 " 108 Recent reviews of these data 109410 indicated a modest, dose-dependent effect of calcium supplementation on blood pressure that may be most important in certain subsets of the population. These subsets include African Americans, 111113 women with gestational hypertension, 83 " 88 or salt-sensitive individuals. 90 " 92 Low calcium intake may be an especially important indicator because very low calcium diets (<400 to 600 mg/d) are most closely associated with elevated blood pressure, 5 ' 20 " 22 -2427 " 4115 and work with experimental models indicates that low calcium diets elevate blood pressure (see below).
Dietary Calcium in Experimental Models of Hypertension
The outcome of calcium supplementation in experimental models of hypertension is much more consistent than it is in humans. As shown in Table 1 , more than 80 studies have manipulated dietary calcium and measured blood pressure. Most have found an inverse relation between calcium intake and blood pressure. This relation has been found in a variety of genetic and experimental models of hypertension, including SHR; strokeprone SHR; Dahl salt-sensitive (DS) rats; Lyon hypertensive rats; deoxycorticosterone-saline (DOC-saline) rats; one-kidney, one clip rats; and remnant kidney 
SNS
SBP indicates systolic blood pressure; VSM, vascular smooth muscle; SHR, spontaneously hypertensive rats; MAP, mean arterial pressure; PTH, parathyroid hormone; SD, Sprague-Dawtey rats; Ang II, angtotensin II; SNS, sympathetic nervous system; WKY, Wlstar-Kyoto rats; CNS, central nervous system; NE, norepinephrine; PTX, parathyroidectomy, RAS, renin-anglotensin system; DOC, deoxycorticosterone; SHRSP, stroke-prone SHR; DS, Dahl salt-sensitive; ANP, atrlal natriuretic peptide; ACI, American Cancer Institute; BP, blood pressure; LVH, left ventricular hypertrophy; PHF, parathyroid hypertensive factor; SHR-S, salt-sensitive SHR; SHR-R, salt resistant SHR; LHR, Lyon hypertensive rats; 2K1C, two-kidney, one clip hypertensive rats; ADX, adrenalectomized rats; and aldo, aldosterone.
*Unless noted otherwise.
rats. Normotensive rats, such as WKY, Wistar, Fisher 344, and Sprague-Dawley rats, are also responsive to dietary calcium, but the changes in blood pressure are smaller and take prolonged periods of time to develop.
The most common method of manipulating dietary calcium has been by altering CaCO 3 in dry food. However, CaCl 2 in the drinking water has proved to be an effective means of altering blood pressure as well. The 92 Tenner et al 1989 183 Togari et al 1990 194 Tresham et al 1988 195 Wleceketal 1989' 
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However, 1.0% is often considered the normal level because it is the amount contained in major brands of rat chow.
Based on the available literature, it appears that studies which have used fairly substantial differences in calcium intake (5-to 10-fold) between treatment groups have most consistently reported significant differences in blood pressure. Using five diets that ranged between 0.1% and 2.0% calcium, Karanja et al 157 reported a nonlinear inverse relation between the calcium content of the diet and blood pressure in SHR maintained on a concurrent high sodium chloride diet. When calcium was varied by a factor of two or less, differences in blood pressure were less likely.
The overall composition of the diet has varied considerably, reflecting the variety of dietary sources available to researchers around the world. The nutrients that have received the most attention in relation to calcium are other electrolytes. Sodium, chloride, potassium, magnesium, and phosphorus have frequently been modified along with calcium. Less consideration has been given to other factors in the diet, even though other nutrients may influence calcium metabolism. Fiber content is known to influence the absorption of calcium, 202 and the lipid profile of the diet has been shown to interact with calcium to alter blood pressure. 158 How rapidly blood pressure changes after dietary manipulation depends on the age of the animal as well as the composition of the diet. With normal levels of sodium chloride in the diet, 3-week-old animals show alterations in blood pressure to dietary calcium within 4 to 5 days. 141 At 4 weeks of age, 2 weeks or longer may be required before a change in blood pressure is observed, whereas at 6 weeks of age, more than 2 months may pass without a change in blood pressure. 51 In contrast, the effects of calcium may be apparent within 2 weeks in an 8-week-old salt-sensitive SHR if the animal is on a high sodium chloride diet. The diet-related changes in blood pressure do not appear to be due to variations in body weight. Karanja et al 157 reported that weight gain was greatest in SHR consuming 1.0% calcium diets, yet the rate of blood pressure rise was about half that of rats fed 0.25% calcium diets. It is of interest to note that animals on enriched calcium diets eat as much as 30% more but weigh less than animals on normal calcium diets.
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Proposed Mechanisms for the Antihypertensive Actions of Calcium
A multitude of potential mechanisms may explain the effect of dietary calcium on blood pressure. As dietary calcium changes, so do PTH, calcitriol, calcitonin, calcitonin gene-related peptide (CGRP), atrial natriuretic peptide (ANP), renin-angiotensin system activity, sympathetic nervous system activity, metabolism of other electrolytes, calcium binding proteins, intracellular free calcium levels, membrane-bound calcium, and electrolyte fluxes. Any one or combination of these changes could be responsible for altering blood pressure. In the following sections, several mechanisms that have been postulated to mediate the effects of dietary calcium on blood pressure will be explored. The proposed mechanisms are summarized in Table 2 .
Vascular Smooth Muscle
Calcium plays a key role in vascular smooth muscle function. Calcium influx through receptor-and voltageoperated calcium channels is thought to initiate vascular contraction, and the fall in the intracellular free calcium concentration is thought to result in relaxation or vasodilation. Therefore, how the vascular smooth muscle cell (VSMC) handles calcium is critical to vascular tone and blood pressure. Anything that causes a perturbation in the processes that control cellular regulation of calcium would very likely change vascular tone.
In the following section, the effects of dietary calcium on VSMC regulation of calcium will be considered. In some instances, the effects on vascular smooth muscle are estimated from the effect of dietary calcium on platelets or other cell types. Although there are impor- tant differences among cell types, it is assumed that the effect of dietary calcium on cellular calcium regulation is not restricted to VSMCs, and therefore, other cell types can be used as surrogates. This assumption is bolstered by the work of Oshima et al, 68 who observed a decline in platelet and lymphocyte intracellular free calcium in stroke-prone SHR maintained on high calcium/high sodium chloride diets. In their study, strokeprone SHR were maintained on low or high calcium (0.2% versus 2.0%) and either low or high sodium (0.3% versus 3.1%). Animals on high sodium/low calcium diets had elevated blood pressure and high levels of basal and stimulated intracellular free calcium in both circulating platelets and intrathymic lymphocytes. Supplemental dietary calcium corrected the abnormalities in intracellular calcium. The similarity of findings in two different cell types indicates that the dietary calcium-induced correction of intracellular abnormalities of calcium metabolism may be a generalized phenomenon and not cell specific.
Membrane Stabilization
Based on numerous reports of abnormalities in cell membrane transport systems associated with hypertension, Bohr and colleagues 204 have hypothesized that there is a defect in the lipid bilayer of vascular smooth muscle membrane in hypertensive individuals. This defect results in decreased membrane fluidity and enhanced excitability as a consequence of increased Ca 2+ flux across the cell membrane. Bohr and coworkers 133 -204209 have provided persuasive evidence that increased extracellular calcium causes a reduction in vascular contractility through a process of membrane stabilization. Increased binding of calcium to the plasma membrane decreases membrane permeability to both monovalent and divalent cations, resulting in diminished vascular contractility. Membrane stabilization is an attractive hypothesis for explaining the effects of dietary calcium, but most studies of membrane stabilization have been done in vitro using extracellular calcium levels that may not correspond to the magnitude of change that might be expected from manipulations of dietary calcium. To evaluate the effect of dietary calcium on cellular function, Furspan and Bohr 210 fed stroke-prone SHR and WKY rats either 1% or 2.5% calcium diets for 10 weeks. They then measured blood pressure, serum ionized calcium, and lymphocyte intracellular sodium, potassium, and calcium, as well as net passive fluxes of sodium and potassium. They found that supplemental calcium reduced blood pressure, increased serum ionized calcium, reduced net potassium efflux, and reduced free ionized calcium within the lymphocyte. The changes were attributed to increased extracellular calcium and resultant membrane stabilization in the calcium-supplemented stroke-prone SHR.
Na,K-ATPase
In a series of studies, Porsti et al 182 -184 reported that increasing dietary calcium lowers blood pressure and improves vascular relaxation in the SHR. They found that supplemental calcium normalized DOC-induced elevations of blood pressure as well as the increased vascular contractility to norepinephrine that is characteristic of vessels from DOC-treated animals. 182 Dietary calcium did not alter contractility to norepinephrine in SHR not treated with DOC, suggesting that the change in maximal contractility resulted from a calcium-induced modulation of the DOC treatment. On the other hand, supplemental calcium did enhance relaxation to sodium nitroprusside and acetylcholine in both the DOC-calcium group and the calcium-supplemented control SHR. The authors suggest that the improved relaxation may have been a consequence of increased Na,K-ATPase activity. In a previous report, they noted that potassium-induced relaxation of mesenteric arterial rings was augmented by calcium supplementation in SHR. 183 Because ouabain was able to prevent the relaxation, the difference between diet groups was attributed to increased Na,K-ATPase activity. This outcome is consistent with the notion of a reciprocal relation between intracellular calcium and Na,KATPase activity; as intracellular calcium declines, Na,K-ATPase activity increases.
2 " The results from Porsti et al 182 -184 are commensurate with other findings showing the maximal contractility to norepinephrine in intact vessels is not altered by supplemental dietary calcium. Aorta, mesenteric, and tail arteries from animals fed high calcium diets have not shown diminished reactivity to norepinephrine or potassium chloride (KC1).* If anything, there may be increased contractility. Ambrozy et al" 6 found increased sensitivity to phenylephrine in Zucker obese and lean rats fed high calcium diets, whereas Pernot et al 177 found an increase in maximal contractility to norepinephrine in Lyon hypertensive rats on high calcium diets.
Despite the in vitro results, blood pressure reactivity in vivo has been reported to be reduced to norepinephrine in animals fed supplemental calcium. Several investigators have reported diminished pressor responses to norepinephrine in both hypertensive 142 -153180 and normotensive 120132 rats fed high calcium diets. These results would not appear to be a consequence of diminished vascular contractility given the results from isolated vessels cited above. However, the in vivo results may be related to circulating factors that modify the response to norepinephrine or to difficulties related to vascular relaxation.
Ca
2+ -ATPase
Just as Furspan and Bohr 210 observed lower levels of intracellular free calcium in lymphocytes from animals on high calcium diets, Porsti et al 183 reported lower levels of intracellular free calcium in platelets isolated from animals maintained on supplemental calcium diets. These favorable changes in intracellular calcium regulation may be related to increased Ca 2+ -ATPase activity. Porsti et al 182 and Wuorela et al 198 observed an increase in the maximal velocity of calcium transport by "inside-out" red blood cell vesicles from SHR on calcium-supplemented diets. The greater velocity of calcium transport is indicative of increased Ca 2+ -ATPase activity. Wuorela et al 198 also reported that nitroprussideinduced relaxation of norepinephrine-contracted mes-
• References 116, 128, 129, 141, 177, 183, 184. enteric arterial rings was enhanced in calciumsupplemented animals, perhaps as a consequence of an increased ability to extrude calcium from the cell.
Calmodulin
Using duodenal enterocytes, Roullet et al 212 223 These observations suggest that elevated PTH may in some way be responsible for the high blood pressure. If so, dietary calcium may lower blood pressure by suppressing PTH. However, such an effect would be paradoxical because PTH is a potent vasodilator. Intravenous injections of PTH result in a prompt, dose-dependent fall in blood pressure. 224 - 225 Nevertheless, parathyroidectomy has been consistently shown to lower blood pressure in animal models of hypertension. 226228 Furthermore, transplantation of parathyroid glands between WKY rats and SHR results in higher blood pressure in the WKY rat and lower blood pressure in the SHR. The resolution of the paradox may be related to a number of factors. First, it should be noted that at physiological concentrations in blood, PTH does not appear to be vasoactive. 231233 Thus, the influence of PTH on blood pressure may be independent of its vasodilating effects. Second, prolonged exposure to low calcium diets, which elevates circulating PTH levels, 50 diminishes the magnitude of the blood pressure decline after an acute injection of PTH. 118 The potential development of tolerance to the vasodilator effects of PTH may be associated with a simultaneous enhancement in response to other vasoactive drugs. This situation would be analogous to the effect of alcohol exposure on arterial pressure. Acutely, alcohol is a vasodilator, but with continued exposure it is associated with hypertension. Several studies have shown that as the vasodilator effects of alcohol decline, there is an increase in intracellular free calcium in VSMCs that may favor enhanced responses to other agonists (for review, see Reference 234) .
PTH may act as a calcium ionophore to promote increased intracellular calcium levels in VSMCs and thereby increase vascular tone. The possibility of PTH as an ionophore in vascular smooth muscle is suggested by findings that low concentrations of PTH induce calcium influx into isolated cardiac cells 235 as well as osteoblasts. 23 * The relation between PTH and platelet intracellular calcium has been examined in humans and in rats. Oshima et al 237 could find no effect of parathyroidectomy on platelet free intracellular calcium in SHR. In humans, there is little intercorrelation between intracellular free calcium and PTH activity. 238 Thus, the evidence does not favor the ionophoric effect of PTH in hypertension.
It is possible that PTH has central nervous system effects that promote an elevation of blood pressure. In a brief article, Delbarre et al 239 reported that intracerebral ventricular administration of PTH resulted in significantly elevated blood pressure in the SHR. Although this study is apparently the only one of its kind, there are other indications that PTH has central nervous system effects. Geiger et al 240 reported altered cyclic AMP in various brain regions in the rat that were attributable to variations in PTH. More recently, Islam et al 241 found evidence that PTH diminished synaptosomal phospholipid content in uremic rats. In a subsequent study, Smogorzewski et al 242 reported that PTH was responsible for a higher calcium content in rat brain synaptosomes as well as reduced Na,K-ATPase activity. PTH also modified epinephrine content, uptake, and release.
An additional explanation for the PTH paradox is the putative parathyroid hypertensive factor. Lewanczuk et al 243 have reported the presence of a circulating hypertensive factor that is present in both SHR and human plasma. 244 When injected into normotensive rats for bioassay, the hypertensive factor stimulates vascular smooth muscle calcium uptake and causes an elevation in blood pressure with a time lag of about 2 hours. Parathyroidectomy eliminates the circulating factor, suggesting that the parathyroid gland is the source. 226 If so, this would shift focus away from PTH to the parathyroid gland itself and in so doing would reconcile the disparate blood p'ressure results that have previously been ascribed to PTH. Pertinent to this review, the purported factor is responsive to variations in dietary calcium. Increased dietary calcium reduces circulating hypertensive factor, whereas restricted calcium increases it. 167 Calcitriol. As mentioned previously, low calcium diets provoke an increase in the synthesis and release of 1,25(OH) 2 2 vitamin D 3 in SHR produced only a transient elevation in blood pressure after 5 weeks of treatment, suggesting a modest effect of the hormone on blood pressure. 256 As reported in previous studies, vascular contractility was significantly enhanced in the SHR.
Thus, considering the direct effects on the vasculature, the observation of potentiated pressor responses, and recent reports of elevated blood pressure, 1,25(OH) 2 vitamin D 3 should be considered as an agent that has the potential to alter blood pressure. Further work is needed to understand the cellular events underlying the vascular smooth muscle response to calcitriol.
Calcitonin. In general, the effects of calcitonin on calcium regulation are opposite to those of PTH and 1,25(OH) 2 vitamin D 3 . Although supplemental dietary calcium can be expected to elevate calcitonin levels, calcitonin has not been routinely measured in studies of the effect of dietary calcium manipulations on blood pressure. Nevertheless, there is evidence that calcitonin may have vasoactive properties.
There have been conflicting reports on the relation of calcitonin to blood pressure. Bindels et al 49 found significantly elevated calcitonin in young SHR, along with reduced serum ionized calcium and elevated 1,25(OH) 2 vitamin D 3 . Presumably, the disparate results between elevated calcitonin in the presence of reduced serum ionized calcium were related to phosphate metabolism. These findings suggest that calcitonin is associated with elevated blood pressure. In fact, Clementi et al 257 reported elevated blood pressure after intracerebroventricular administration of 0.4 IU salmon calcitonin. The increased blood pressure was accompanied by increased plasma renin activity. It is unlikely that the increased plasma renin activity contributed to the elevation of blood pressure, because intravenous and intramuscular administration of calcitonin elevated plasma renin activity without altering blood pressure.
Other investigators have found conflicting evidence. Delbarre et al 239 observed a reduction in blood pressure with intracerebroventricular administration of calcitonin but an elevation of blood pressure with peripheral administration. Wegener and McCarron 258 were unable to detect any effect of calcitonin on blood pressure through intravenous administration.
Additional research will be needed to assess the effects of calcitonin on blood pressure and its relation to dietary calcium. Calcitonin may well have an influence on blood pressure via the central nervous system. Although calcitonin is a thyroid hormone, a number of calcitonin receptors in the brain 259 mediate a variety of effects, including anorexia, 260 analgesia, 261 and altered pituitary release of hormones. 262 However, at the present time there is insufficient evidence to evaluate the possibility that calcitonin modulates blood pressure via the central nervous system.
Calcitonin gene-related peptide. In contrast to calcitonin, CGRP is known to be vasoactive. This 37-amino acid neuropeptide results from alternative processing of the calcitonin gene. It is widely distributed in the central and peripheral nervous systems 263 and is one of the most potent vasodilators yet discovered. Intravenous infusion of CGRP produces marked hypotension through a reduction in total peripheral resistance. 264265 Central nervous system administration of CGRP produces variable effects depending on the dose and site of administration. For example, injection of 0.2 pmol CGRP into the nucleus tractus solitarius produced a depressor response, whereas 2 pmol resulted in a pressor response. 266 Likewise, injections into the central nucleus of the amygdala resulted in a pressor response, 267 but intrathecal injections caused a reduction in blood pressure. 268 Of particular interest are observations that levels of CGRP in spinal cord vary with dietary calcium. DiPette et al 269 demonstrated that low levels of dietary calcium reduced dorsal horn CGRP content, and supplemental calcium increased CGRP levels. Although DiPette et al 269 did not assess circulating levels of CGRP in their study, others 270 have found it to be lower in SHR than WKY rats. Given the vasoactive properties of CGRP and its presence in central and peripheral nervous system sites involved in cardiovascular regulation, CGRP may be involved in the blood pressure alterations that result from dietary calcium manipulations.
Sympathetic Nervous System
There are consistent reports of altered sympathetic nervous system activity associated with variations in dietary calcium. Winternitz et al 271 - 272 and Oparil et al 273 have reported that increased sodium chloride causes an elevation of blood pressure in salt-sensitive SHR. The increased blood pressure is associated with elevated circulating norepinephrine and reduced hypothalamic norepinephrine. 274 Provision of supplemental calcium reverses the increased blood pressure induced by sodium chloride while normalizing circulating and central nervous system changes in catecholamines.
-
199
- 200 Peuler et al 178 reported that 4.8% calcium diets reduce blood pressure in DS rats by attenuating sympathetic nervous system outflow. Interestingly, 2% calcium diets aggravated hypertension in this strain 179 while reducing blood pressure in the stroke-prone SHR. 180 There are several possible mechanisms through which calcium may modify the sodium chloride effect on sympathetic nervous system outflow. One possibility is that the electrolytes may interact within the central nervous system. Infusion of sodium chloride into the cerebral ventricles 275 or nucleus tractus solitarius 276 has been shown to cause an elevation of blood pressure. In contrast, intracerebroventricular calcium causes a reduction in blood pressure. 277 Therefore, it appears that both calcium and sodium chloride are reciprocally vasoactive in the central nervous system. There is evidence that manipulations of dietary calcium result in altered levels of central nervous system calcium. Longterm alterations in dietary calcium have been shown to change cerebrospinal fluid and brain levels of calcium in rats. Harris et al 278 found the reduction in calcium levels to be greatest in the brain stem (24%) after 4 weeks of restricted dietary calcium (0.02%), with the soluble and microsomal fractions of calcium selectively reduced. Likewise, Tai et al 279 found that calcium fluxes into brain and cerebrospinal fluid were linearly related to plasma ionized calcium. Thus, it appears that although the brain is protected from acute changes in serum ionized calcium by low cerebrovascular permeability to calcium, long-term changes in dietary calcium can alter brain levels of calcium, albeit to a lesser extent than the changes in serum calcium. 280 The interaction between sodium and calcium may occur at the receptor level. Gavras 281 has hypothesized that sodium may directly influence neural activity and cause increased sympathetic nervous system outflow by attenuating the affinity of a 2 -adrenergic receptors for their agonists. Because activation of hypothalamic a 2 receptors causes inhibition of sympathetic outflow, reduced affinity would result in disinhibition of the sympathetic system. In contrast to sodium, divalent cations such as calcium increase the affinity of the receptors for the ligand.
Whether changes in central nervous system calcium levels are responsible for alterations in central catecholamine levels remains to be demonstrated. Nevertheless, reductions in dietary calcium comparable to those used to modify central nervous system calcium levels are reported to alter central nervous system norepinephrine levels. Baksi 122 reported that 8 weeks of a 0.005% calcium diet reduced hypothalamic norepinephrine and dopamine content in Sprague-Dawley rats. Restricted dietary calcium has also been reported to alter peripheral catecholamine levels. Baksi and Hughes 283 and Hagihara et al 284 reported altered adrenal catecholamine levels with reduced calcium diets, and Luft et al 167 observed reduced epinephrine levels and epinephrine responses to stress in stroke-prone SHR on high calcium diets. Scrogin et al 188 also observed diminished circulating epinephrine in calcium-supplemented SHR. Felicetta et al 285 observed an increased urinary dopamine-norepinephrine excretion ratio during a high calcium/high sodium chloride diet. Other investigators have reported no difference in circulating catecholamines as a consequence of altered calcium diets. 144 reported diminished pressor responses to exogenous norepinephrine in SHR on high calcium diets. The reduced pressor response did not occur in response to angiotensin II, suggesting that it was not due to a generalized change in vascular responsiveness. Doris, 132 Kageyama et al, 152154 Baksi, 121 and Peuler 180 have reported similar results with regard to norepinephrine.
The reduced responsiveness to norepinephrine may be related to altered adrenergic receptor activity. Hatton et al 144 demonstrated that dietary calcium specifically modulates the a r adrenergic receptor. Blockade of a,-adrenergic receptors with phentolamine or prazosin eliminated the difference in blood pressure that prevailed in animals on high and low calcium diets. Blockade of a 2 -, f} { -, or ft-adrenergic receptors had no such effect. Likewise, pharmacologic reduction of blood pressure with CGRP, sodium nitroprusside, or the converting enzyme inhibitor captopril had no differential effect on blood pressure. The results of this study strongly suggest that dietary calcium modifies the apadrenergic receptor. The nature of the effect remains to be determined, but preliminary data indicate that there may be a difference in receptor expression because binding to tritiated prazosin was greater in kidneys from animals fed low calcium diets.
Electrolyte Interactions
A change in the level of one dietary electrolyte can have extensive ramifications on other dietary electrolytes. Increased dietary calcium, for example, can increase sodium excretion, reduce magnesium absorption, and reduce circulating phosphorus levels. Likewise, increasing sodium chloride in the diet causes calcium wasting, but if sodium levels are altered independently of chloride, calcium is unaffected. Consequently, when manipulation of a dietary electrolyte is shown to have an effect on blood pressure, the possibility exists that the blood pressure effect is due to reciprocal changes in other electrolytes.
Phosphate depletion. Early in the study of the effect of dietary calcium on blood pressure, Lau and coworkers 163 proposed that calcium-induced phosphate depletion accounted for the blood pressure reduction. However, rather than a positive relation between phosphate and blood pressure as predicted by Lau et al, 162 Bindels et al 49 demonstrated that supplementing the SHR diet with phosphate results in a blood pressure reduction during mid-adolescence. To specifically determine the role of phosphorus in calcium-induced reductions in blood pressure, Tamura 192 varied both calcium and phosphate and found that calcium lowered blood pressure regardless of serum phosphate levels. Thus, it would appear that the effect of calcium on blood pressure is relatively independent of phosphate.
Magnesium. Dietary calcium intake can have a pronounced effect on magnesium metabolism. 192 With increased dietary calcium intake, serum magnesium levels decline. Furthermore, observations of increased intracellular calcium with low calcium diets suggest that intracellular magnesium may be reduced. 244 Because of the interactive effects of dietary calcium and magnesium, it has been suggested that some of the effect of calcium on blood pressure may be mediated through alterations in magnesium. Indeed, Tamura 192 found a significant positive correlation of serum magnesium levels with systolic blood pressure across groups receiving different levels of dietary calcium. However, in a factorial study of calcium and magnesium, Evans et al 133 found no effect of magnesium on blood pressure and no interactive effects of the two cations on blood pressure.
Sodium chloride/calcium interactions. Numerous studies have found that calcium attenuates sodium chloridedependent, low-renin hypertension. Calcium lowers blood pressure in several salt-sensitive models of hypertension, including DOC-saline rats, 91130145154176186 reduced renal mass/saline rats, DS rats, 156173178182 saltsensitive SHR, 149172199200 salt-fed WKY rats, 131132 angiotensin II-salt rats, 119 and adrenalectomy/aldosterone-induced hypertension. 190 The mechanisms through which calcium attenuates salt-induced forms of hypertension have not been identified, but numerous candidates have been suggested.
Calcium-induced natriuresis. Increasing dietary calcium facilitates natriuresis in a number of ways. Increased circulating ANP, reduced sympathetic nervous system outflow, reduced a,-adrenergic receptor activity, reduced angiotensin II receptor expression, reduced circulating PTH, and direct effects of calcium on sodium excretion at the proximal tubule may all play a role. The most familiar natriuretic effect of calcium is the interaction that occurs at the renal level. Increasing calcium facilitates natriuresis and diuresis in part by inhibiting sodium reabsorption in the proximal tubule. 286 Conversely, reducing serum ionized calcium levels by acute volume expansion retards natriuresis and diuresis. 287 This occurs, at least in part, as a consequence of increased circulating PTH acting on the tubules to alter production of prostaglandins, with a resultant reduction in sodium excretion 288 as well as direct effects of calcium on prostaglandin production. Less well known are the effects of increasing dietary calcium on other systems that promote natriuresis. Geiger et al 137 and Kohno et al 159 have reported increased circulating ANP after supplemental calcium diets. Such an increase in ANP would promote natriuresis as well as cause peripheral vasodilation and reduced blood pressure. Levi and Henrich 289 recently reported that high calcium diets reduced angiotensin II binding in renal brush-border membranes and decreased brush-border membrane Na-H antiport activity in SHR. Angiotensin II increases proximal tubular sodium transport by increasing Na-H antiport activity. Decreased activity in this system would enhance sodium excretion.
The effect of calcium on sympathetic nervous system activity would also facilitate sodium excretion. The reduction in sodium chloride-induced increases in sympathetic nervous system outflow that have been reported 172 can be expected to result in increased sodium excretion, as would the diminished a,-adrenergic activity during high calcium diets, as reported by Hatton et al. 144 Given the multiple mechanisms through which increased dietary calcium facilitates sodium excretion, it is not surprising that increasing the proportion of calcium in the diet results in natriuresis.* In some models of hypertension, natriuresis may be an important component of the antihypertensive effect of dietary calcium. This would apply regardless of how sodium chloride might provoke hypertension, because removal of sodium chloride would remove the initial stimulus for elevated blood pressure.
Not all evidence favors a natriuretic explanation for the blood pressure effects of dietary calcium. In SHR that are not salt sensitive, increasing dietary sodium chloride does not alter blood pressure. However, increasing dietary calcium does lower blood pressure. Studies from our laboratory 170 and that of Harriet et al 290 have demonstrated that the antihypertensive action of calcium may actually be enhanced by simultaneous sodium chloride supplementation. This interactive effect of these nutrients is not likely to be related to natriuresis because, as mentioned above, manipulation of sodium chloride alone does not alter blood pressure in these animals.
Thus, it may be necessary to distinguish between hypertensive models when assessing the interactive effects of dietary calcium and sodium chloride. For models in which calcium prevents a sodium chloride-induced elevation in blood pressure, such as in DOCsaline hypertension, natriuresis might be suspected. Otherwise, natriuresis seems less likely. Even when natriuresis is an unlikely cause for the blood pressurelowering effect of dietary calcium, as in the SHR, sodium chloride and calcium may interact to potentiate the antihypertensive effects of supplemental calcium.
Sodium chloride-induced calciuresis. Just as calcium promotes natriuresis, sodium chloride promotes calciuresis. Consequently, as sodium chloride is increased in the diet, more calcium is excreted. Resnick and colleagues 244291 -292 hypothesize that this dietary sodium chloride-induced calciuresis results in reduced serum ionized calcium and increased circulating levels of calcium-regulating hormones including calcitriol, PTH, and/or parathyroid hypertensive factor. In turn, these hormones stimulate cellular calcium uptake and disrupt cellular electrolyte balance, resulting in elevated blood
• References 54, 91, 119, 131, 137, 149, 156, 159, 173, 190, 191, [286] [287] [288] pressure. According to this hypothesis, calcium supplementation increases available calcium, prevents the fall in ionized calcium that provokes the increase in calcium-regulating hormones, and reverses the salt-induced hypertension.
Favoring this hypothesis are indications that increased dietary sodium chloride causes renal wasting of calcium 293294 and stimulates calcitriol and PTH production. 293 Elevated calcitriol and PTH have been found in low-renin human hypertension 292 as well as in experimental forms of hypertension. 91 Kotchen et al 295 reported that after 5 days of a high salt diet, young DS rats exhibited increased calcium excretion in both urine and feces, whereas ionized calcium was reduced and calcitriol and PTH were elevated relative to Dahl saltresistant rats. The differences in calcium excretion occurred with no changes in blood pressure. The excessive calcium excretion could be avoided by sodium loading with anions other than chloride, suggesting that the combination of sodium and chloride is critically important to the calciuresis that occurs. It is notable that high sodium diets that do not contain chloride also do not cause hypertension in the DS rat. Similarly, Kurtz and Morris 161 found increased calcium excretion in DOC-saline hypertension when the animals were fed sodium chloride. However, if an equimolar amount of sodium bicarbonate was substituted for sodium chloride, the increases in both calcium excretion and blood pressure were reversed.
To test the hypothesis that sodium chloride causes hypertension as a consequence of alterations in calciumregulating hormones, Resnick et al 186 fed supplemental dietary calcium to low-renin, DOC-salt hypertensive rats and to renin-dependent Goldblatt hypertensive rats. Calcium excretion was substantially greater in the DOC-salt rats relative to the two-kidney, one clip Goldblatt rats. Modest increases in dietary calcium (1.2% versus 1.8%) caused a reduction of blood pressure in the DOC-salt animal but resulted in an increase in blood pressure in the Goldblatt model of hypertension.
Although these results are dramatic, other investigators have found that supplemental dietary calcium reduces renovascular hypertension. Kageyama et al 153 reduced blood pressure in two-kidney, one clip Goldblatt hypertensive rats by providing supplemental calcium (1.5%) in the drinking water. The reduction in blood pressure was accompanied by a suppression of plasma renin and aldosterone as well as diminished pressor responses to norepinephrine, leading the authors to conclude that the reduction in blood pressure may have been a consequence of reduced renin-angiotensin system activity.
Nonvascular Mechanisms
Nonvascular mechanisms must also be considered in explaining the role of dietary calcium in blood pressure regulation. Tordoff and colleagues 296 ' 298 have provided important new insights as to potential nonvascular mechanisms. Their studies in three genetically distinct animal models indicate that dietary calcium regulates sodium chloride appetite or intake. Low dietary calcium stimulates sodium chloride intake, and higher intakes of calcium suppress sodium chloride appetite. Thus, while volume may not be changed at higher calcium intakes, exposure to sodium chloride is reduced with potentially important effects on sodium-regulating hormones such as renin, aldosterone, and angiotensin II.
Change in blood viscosity is another nonvascular mechanism potentially affected by dietary calcium. Hatton et al 143 have measured changes in hematocrit that occur with calcium supplementation as an indirect assessment of viscosity. They found that there is an inverse relation between calcium intake and hematocrit. However, the changes in blood pressure observed with the higher calcium intake were independent of changes in hematocrit.
Hamet and Tremblay 2 " have linked correction of the abnormal HSP70 gene expression of experimental hypertension to increased dietary calcium intake. The HSP70 gene, which exists in the major histocompatibility complex and segregates closely with hypertension, has its expression corrected (suppressed) by dietary calcium.
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Summary
More than 80 studies have reported lowered blood pressure after dietary calcium enrichment in experimental models of hypertension. The evidence presented here suggests that dietary calcium may act concurrently through a number of physiological mechanisms to influence blood pressure. The importance of any given mechanism may vary depending on the experimental model under consideration.
Supplemental dietary calcium is associated with reduced membrane permeability, increased Ca 2+ -ATPase and Na,K-ATPase, and reduced intracellular calcium. These results suggest that supplemental calcium may limit calcium influx into the cell and improve the ability of the VSMC to extrude calcium. This could be a direct effect of calcium on the VSMC or an indirect effect mediated hormonally.
The calcium-regulating hormones have all been found to have vasoactive properties and therefore may influence blood pressure. Furthermore, CGRP and the proposed parathyroid hypertensive factor are both vasoactive substances that are responsive to dietary calcium. Therefore, diet-induced variations in calciumregulating hormones may influence blood pressure.
Modulation of the sympathetic nervous system is another important way that dietary calcium can influence blood pressure. There is evidence of altered norepinephrine levels in the hypothalamus as a consequence of manipulations of dietary calcium as well as changes in central sympathetic nervous system outflow. Dietary calcium has also been shown to specifically modify a r adrenergic receptor activity in the periphery.
In some experimental models of hypertension, dietary calcium may alter blood pressure by changing the metabolism of other electrolytes. For example, the ability of calcium to prevent sodium chloride-induced elevations in blood pressure may be attributed to natriuresis. However, natriuresis does not account for all of the interactive effects of calcium and sodium chloride on blood pressure. Sodium chloride-induced hypertension may be due in part to calcium wasting and subsequent elevation of calcium-regulating hormones. Chloride is an important mediator of this effect because it appears that sodium does not cause calcium wasting when it is not combined with chloride.
More attention to the central nervous system effects of dietary calcium is needed. Not only can calcium itself influence neural function, but many of the calciumregulating hormones appear to affect the central nervous system. The influence of calcium and calciumregulating hormones on central nervous system activity may have important implications for blood pressure regulation and also may extend to other aspects of physiology and behavior.
